Event related potentials and cognitive evaluation in Wilson's disease with and without neurological manifestation;Nörolojik bulguları olan ya da olmayan wilson hastalıg̈ı'nda olaya bag̈lı potansiyeller ve bilişsel deg̈erlendirme

Journal of Neurological Sciences

Volumn 28, Issue 1, 2011, Pages 79-85

  Günther, Peter ^a   Villmann, Thomas ^b   Hermann, Wieland ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES MITTWEIDA   (Germany)

^c Paracelsus Klinik   (Germany)

Author keywords

Cognitive impairment; Event related potentials; P300; Wilson's disease

Indexed keywords

PENICILLAMINE; ZINC;

ADULT; AGED; ARTICLE; ATAXIA; BRADYKINESIA; CLINICAL ARTICLE; COGNITIVE DEFECT; DEMENTIA; DYSARTHRIA; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HUMAN; HYPOKINESIA; LATENT PERIOD; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; STRUCTURED INTERVIEW; TREMOR; WILSON DISEASE;

EID: 79953765125     PISSN: 13001817     EISSN: 13021664     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Barthel H, Hermann W, Kluge R et al.: Concordant Pre- and Postsynaptic Deficits of Dopaminergic Neurotransmission in Neurologic Wilson Disease. AJNR 2003; 24: 234-238.
2. Bickel H, Mösch E, Förstl H: Kognitives Screening und Vorhersage von Demenzen mithilfe des SIDAM - Screening of Cognitive Functions and the Prediction of Incident Dementia by Means of the SIDAM. Psychiat Prax 2007; 34: 139-144
3. Biesold D, Günther K: Improved method for investigation of copper metabolism in patients with Wilson's disease using 64Cu. Clinica Chimica Acta 1972; 42: 353-359.
4. Bonanni L, Franciotti R, Onofrj V et al.: Revisiting P300 cognitive studies for dementia diagnosis: Early dementia with Lewy bodies (DLB) and Alzheimer disease (AD). Neurophysiol Clin. 2010; 40: 255-265.
5. Brown WS, Marsh JT, LaRue A: Event-related potentials in psychiatry: differentiating depression and dementia in the elderly. Bull Los Angeles Neurol Soc 1982; 47: 91-107.
6. Dening TR, Berrios GE: Wilson's disease-psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989; 46: 1126-1134
7. Eggers B, Hermann W, Barthel H et al.: The degree of depression in Hamilton rating scale is correlated with the density of presenaptic serotonin transporters in 23 patients with Wilson's disease. J Neurol 2003; 250:576-580
8. Folstein MF, Folstein SE, McHugh PR: Minimental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
9. Goodin DS, Squires KC, Henderson BH et al.: Agerelated variations in evoked potentials to auditory stimuli in normal human subjects. Electroencephalogr Clin Neurophysiol 1978; 44: 447-458
10. Hermann W, Barthel H, Hesse S et al.: Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal regions. J Neurol 2002; 249: 896-901.
11. Hermann W, Günther P, Hahn S et al.: Zerebrales MRT und evozierte Potentiale bei Patienten mit Morbus Wilson. Nervenarzt 2002; 4: 349-354
12. Hermann W, Kühn HJ, Merle U et al.: Morbus Wilson. In: Leitlinien der Neurologie, 3. Auflage, Thieme Stuttgart; 2005; pp121-126.
13. Hermann W, Günther P, Kühn HJ et al.: FAEP und Mophometrie des Mesenzephalon bei Morbus Wilson. Akt Neurol 2007; 34: 1-8
14. Hermann W, Günther P, Kühn HJ et al.: Pyramidale Schädigung im Vergleich zur extrapyramidalmotorischen Beeinträchtigung bei Patienten mit Morbus Wilson, Klin Neurophysiol 2007; 38: 216-221
15. Kukull WA, Larson EB, Tery L et al.: The minimental state examination score and the clinical diagnosis of dementia. J Clin Epidemiol 1994; 47:1061-1067
16. Lai CL, Lin RT, Liou LM, Liu CK: The role of eventrelated potentials in cognitive decline in Alzheimer's disease. Clin Neurophysiol. 2010; 121: 194-199.
17. Maier-Dobersberger T; Morbus Wilson. Diagnosestellung mit konventionellen und molekularbiologischen Methoden. Dtsch med Wschr 1999; 124: 493-496.
18. Polich J: Meta-analysis of P300 normative aging studies. Psychophysiology 1996; 33: 334-353
19. Portala K, Westermark KV, Knorring L et al.: Psychopathology in treated Wilson's disease determinated by means of CPRS expert and selfratings. Acta Psychiatr Scand 2000; 101: 104-109
20. Portala K, Levander S, Westermark K et al.: Pattern of neuropsychological deficits in patients with treated Wilson's disease. Eur Arch Psychiatry Clin Neurosci 2001; 251: 262-268
21. Rathbun JK: Neuropsychological aspects of Wilson's disease. International Journal of Neuroscience 1996; 85: 221-229.
22. Roberts EA, Cox DW: Wilson disease. Bailliere's Clinical Gastroenterology 1998; 12: 237-256.
23. Roth WT, Cannon EH: Some features of the auditory evoked response in schizophrenics. Arch Gen Psychiatry 1972; 27:466-471.
24. van Deursen JA, Vuurman EF, Smits LL, Verhey FR, Riedel WJ: Response speed, contingent negative variation and P300 in Alzheimer's disease and MCI. Brain Cogn. 2009; 69: 592-599.
25. Zaudig M, Mittelhammer J, Hiller W, et al. SIDAM - a structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 1991; 21:225-236.